DNA

Scientists use CRISPR to knock down gene messages early in development

2 hours ago   |   Phys

Since its discovery, scientists have been using the much-lauded gene editing tool CRISPR to alter the DNA of model organisms and uncover the functions of thousands of genes...
Read more ...

CRAFT: Compact genome Representation towards large-scale Alignment-Free daTabase

7 hours ago   |   Oxford Journals

AbstractMotivationRapid developments in sequencing technologies have boosted generating high volumes of sequence data. To archive and analyze those data, one primary step is...
Read more ...

Measuring electron emission from irradiated biomolecules

9 hours ago   |   ScienceDaily

Researchers have successfully determined the characteristics of electron emission when high-velocity ions collide with adenine - one of the four key nucleobases of DNA.
Read more ...

Dihydrolipoamide dehydrogenase moonlighting activity as a DNA chelating agent

16 hours ago   |   Wiley

Abstract Dihydrolipoamide dehydrogenase is a mitochondrial enzyme that comprises an essential component of the pyruvate dehydrogenase complex. Lines of evidence have shown that...
Read more ...

Algorithm created by deep learning finds potential therapeutic targets throughout genome

1 day ago   |   Phys

A team of researchers from New Jersey Institute of Technology and Children's Hospital of Philadelphia have developed an algorithm through machine learning that helps predict...
Read more ...

Faster rates of evolution are linked to tiny genomes

1 day ago   |   ScienceDaily

Inside every cell lies a genome - a full set of DNA that contains the instructions for building an organism. Across the biological world, genomes show a staggering diversity in...
Read more ...

Validation Engineer III - Inovio Pharmaceuticals - San Diego, CA

1 day ago   |   San Diego Biotechnology   |   6 articles

INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases,...From Inovio...
Read more ...

UFGI Publication round-up week 6/29

1 day ago   |   Genetics Institute   |   7 articles

Persistently increased cell-free DNA concentrations only modestly contribute to outcome and host response in sepsis survivors with chronic critical illness. Hawkins RB, Stortz...
Read more ...

UF DNA Day 2020

1 day ago   |   Genetics Institute


Read more ...

Interpreting the Human Genome's Instruction Manual

Interpreting the Human Genome's Instruction Manual

1 day ago   |   News Center

An artistic representation of gene regulating elements, which allow cells with the same genetic code to differentiate into many different tissues and play many varied roles in...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Biogen to Pay Denali $1B to Partner on Parkinson's Drug & Other Neuro Meds

Biogen to Pay Denali $1B to Partner on Parkinson's Drug & Other Neuro Meds

Denali Therapeutics has selected a brain-penetrating Parkinson's disease drug candidate to advance to late-stage testing and Biogen is paying $1 billion to kick off a... Read more ...

AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact

AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact

AbbVie has terminated a research partnership with Editas Medicines, returning to the biotech rights to an experimental gene-editing treatment. It's the second genetic medicines... Read more ...

FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy

FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy

The FDA on Friday approved a new spinal muscular atrophy drug that patients can take at home. Risdiplam is a liquid medicine intended for daily use that was developed by Roche... Read more ...

Five Question Friday: Jo Tang

Five Question Friday: Jo Tang

Welcome to Five Question Friday! This is the first blog post of a new monthly series, where we will introduce you to the employees of GreenLight. You'll get to know our team... Read more ...

Bio Roundup: A Telehealth Combo, FDA's BCMA OK, Biogen's Bet & More

Bio Roundup: A Telehealth Combo, FDA's BCMA OK, Biogen's Bet & More

The novel coronavirus has driven the pharmaceutical industry to upend its research priorities. Big Pharma companies are focusing on vaccine development and a slew of biotechs... Read more ...

Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare

Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare

It will be difficult to compare Moderna, Inc. and Pfizer Inc.'s coronavirus vaccines based on their Phase 3 study designs, some vaccines experts said. “Both trials appeared to... Read more ...

“Murder Hornet” Genome Rapidly Assembled by USDA as Part of Real-Time...

“Murder Hornet” Genome Rapidly Assembled by USDA as Part of Real-Time Invasive Species Response Initiative

With a nickname like “murder hornet,” it's no wonder the two-inch long Asian giant hornet has caused a stir amongst those terrified of insect invasions. Various species of... Read more ...

GlaxoSmithKline Multiple Myeloma Drug Earns FDA's First Anti-BCMA Nod

GlaxoSmithKline Multiple Myeloma Drug Earns FDA's First Anti-BCMA Nod

Patients with advanced multiple myeloma have a new treatment option with the FDA's approval of a GlaxoSmithKline drug that targets B-cell maturation antigen, a protein found on... Read more ...

G1 Vets Launch Arc Therapeutics to Take on New Cancer Target

G1 Vets Launch Arc Therapeutics to Take on New Cancer Target

Three early employees of G1 Therapeutics have launched a new oncology-focused company and raised $6 million to move a preclinical program licensed from their former employer... Read more ...

New Partnership Seeds Microbiome Research

New Partnership Seeds Microbiome Research

At the February workshop organized by the National Microbiome Data Collaborative, the MOU creating the Tri-institutional Partnership for Microbiome Research was formally... Read more ...